Works matching AU Matsuno, Kumi

Results: 8

Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF–PH inhibitor for the treatment of renal anaemia.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 2, p. 185, doi. 10.1007/s00228-019-02813-y

By:

Lentini, Silvia;
Kaiser, Andreas;
Kapsa, Stefanie;
Matsuno, Kumi;
van der Mey, Dorina

Publication type:

Article

Absorption, distribution, metabolism and excretion of molidustat in healthy participants.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 127, n. 3, p. 221, doi. 10.1111/bcpt.13409

By:

Lentini, Silvia;
Mey, Dorina;
Kern, Armin;
Thuss, Uwe;
Kaiser, Andreas;
Matsuno, Kumi;
Gerisch, Michael

Publication type:

Article

Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Imarikiren, a Novel Renin Inhibitor, in Healthy Male Subjects.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 5, p. 607, doi. 10.1111/bcpt.13050

By:

Matsuno, Kumi;
Kuroda, Shingo;
Tanaka, Shingo;
Nakamichi, Hiroyuki;
Kagawa, Tomoya;
Koumura, Emiko

Publication type:

Article

A Randomized, Single‐Center, Double‐Blind, Placebo‐Controlled Multiple‐Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 11, p. 1516, doi. 10.1002/jcph.1142

By:

Matsuno, Kumi;
Tanaka, Shingo;
Hashimoto, Takamasa;
Nakamichi, Hiroyuki;
Kagawa, Tomoya;
Koumura, Emiko

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 3, p. 319, doi. 10.1002/cpdd.381

By:

Matsuno, Kumi;
Nakamura, Koki;
Aritomi, Yutaka;
Nishimura, Akira

Publication type:

Article

Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment.

Published in:

Clinical Drug Investigation, 2018, v. 38, n. 11, p. 1041, doi. 10.1007/s40261-018-0695-4

By:

Shimasaki, Yukio;
Sakaki, Masashi;
Itou, Minoru;
Kobayashi, Tokurou;
Aso, Masako;
Kagawa, Tomoya;
Saiki, Takuya;
Matsuno, Kumi;
Sano, Yuhei;
Shimizu, Kohei;
Kuroda, Shingo;
Koumura, Emiko

Publication type:

Article

Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population.

Published in:

Clinical Chemistry & Laboratory Medicine, 2004, v. 42, n. 5, p. 560, doi. 10.1515/CCLM.2004.095

By:

Matsuno, Kumi;
Kubota, Takahiro;
Matsukura, Yuji;
Ishikawa, Hiroshi;
Iga, Tatsuji

Publication type:

Article

A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.

Published in:

Biomedical Chromatography, 2002, v. 16, n. 7, p. 453, doi. 10.1002/bmc.182

By:

Yamamoto, Takehito;
Kusama, Makiko;
Matsuno, Kumi;
Sugiyama, Erika;
Yamada, Yasuhiko;
Iga, Tatsuji

Publication type:

Article